Discontinued Operations

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

The results of operations from discontinued operations presented below include certain allocations that management believes fairly reflect the utilization of services provided to the Bioscience business segment. The allocations do not include amounts related to general corporate administrative expenses or interest expense. Therefore, the results of operations from the Bioscience business segment do not necessarily reflect what the results of operations would have been had the business operated as a stand-alone entity.

	Three Months Ended
	March 31,
Discontinued Operations (in thousands)	2014
Revenues:
Bioscience product sales and services	$	9,212
Cost of revenues:
Cost of bioscience product sales and services	3,340
Gross margin	5,872
Operating expenses:
Selling and marketing	3,210
Research and development	1,372
General and administrative	287
Restructuring costs	19
Total operating expenses	4,888
Earnings from discontinued operations	984
Other income, net	71
Earnings from discontinued operations before income taxes	1,055
Income tax expense	(430		)
Earnings from discontinued operations	$	625

In connection with the sale of the Bioscience segment, the Company also entered into other agreements designed to facilitate the orderly transfer of business operations to the purchaser of the BioScience business. One agreement is a three year Supply Agreement with the purchaser of the BioScience business where the Company may purchase consumables and systems for the laboratory business and for the first twelve months of the agreement has preferred pricing. Purchases made by the Company of consumables and systems for the three months ended March 31, 2015 and 2014 were $0.1 million and $0.1 million, respectively; and these sales have been eliminated from discontinued operations reported revenue in 2014 because the transaction was intra-entity.